Relistor Injection for Treatment of Opioid-Induced Constipation

Article

This video highlights FDA approved methylnaltrexone bromide (Relistor) injection for the treatment of opioid-induced constipation in patients on continuous medication for pain relief in late-stage illness.

Click here to access this third-party resource.

Related Videos
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
Kaitlin Mayne, MBChB | Credit X.com
Mona Shahriari, MD | Credit Central Connecticut Dermatology
Cindy X. Cai, MD: Impact of Race, Neighborhood on Diabetic Retinopathy Care | Image Credit: Johns Hopkins University
© 2024 MJH Life Sciences

All rights reserved.